<DOC>
	<DOCNO>NCT02546362</DOCNO>
	<brief_summary>The objective pilot open trial investigate efficacy safety e-TNS Cefaly ( R ) device fibromyalgia .</brief_summary>
	<brief_title>CEFALY® Device Treatment Patients With Fibromyalgia</brief_title>
	<detailed_description />
	<mesh_term>Fibromyalgia</mesh_term>
	<mesh_term>Myofascial Pain Syndromes</mesh_term>
	<criteria>1 . Aged from18 65 year 2 . Diagnosed FM accord 2010 ACR Preliminary Diagnostic Criteria Fibromyalgia 3 . Having minimum pain score least 4 010 FIQR pain scale screen baseline 1 . Women : Pregnant , lactate &lt; 6 month post partum 2 . Episodic Chronic Migraine accord diagnostic criterion list ICHDIII beta ( 2013 ) section 1 , migraine 1 , two attack per month . 3 . Change medication act central nervous system ( CNS ) within 28 day start study study 4 . Severe depression i.e . Beck Depression InventoryFast Screen ( BDIFS ) score &gt; 12 5 . Botox injection within 4 month baseline study . 6 . Psychiatric disorder could interfere study participation : bipolar disorder , psychotic disorder dementia . 7 . Suicidal behavior and/or ideation i.e . Columbia Suicide Severity Rating Scale ( CSSRS ) score ≥ 4 precede 2 year 8 . Patients currently take opioid medication 9 . Patients currently take medically prescribe marijuana 10 . Current history precede year alcohol substance abuse include marijuana 11 . Intolerance supraorbital neurostimulation make treatment applicable ( test nociceptive threshold specific Cefaly program ) 12 . Widespread rheumatic disease ( FM ) , evidence inflammatory rheumatic disease 13 . Any unstable medical condition judgment investigator would interfere study participation study assessment . 14 . Implanted active metal electrical device head 15 . Cardiac pacemaker implant wearable defibrillator</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>